Celldex Therapeutics | CLDX - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Agenus USD 58.98M 12.1M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Celldex Therapeutics USD 14.68M 4.32M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Nektar Therapeutics USD 10.03M 744K 2026-03
Northwest Biotherapeutics 31.58M 5.13M 2026-03
Pfizer USD 4.58B 75M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Roche Holding CHF 5.54B 237M 2026-06